Rani Therapeutics (RANI) Institutional Ownership → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free RANI Stock Alerts $3.11 +0.08 (+2.64%) (As of 04:00 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)CurrentInstitutional OwnershipPercentage30.19%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.36 MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$735,839.92 Get RANI Insider Trade Alerts Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RANI Institutional Buying and Selling by Quarter Ad Behind the MarketsInvestors Alert: The Next Big Thing in Weight LossHistory shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...The profit window is closing - don't get left behind! Rani Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024Alpha Square Group S LLC58,946$0.20M0.2%-32.2%0.118% 2/12/2024Stifel Financial Corp50,266$0.17M0.0%-64.6%0.101% 11/13/2023Stifel Financial Corp141,904$0.31M0.0%+84.9%0.286% 8/15/2023Stifel Financial Corp76,760$0.32M0.0%+116.1%0.155% 8/14/2023Tower Research Capital LLC TRC 7,048$29K0.0%+83.7%0.014% 8/11/2023Renaissance Technologies LLC88,201$0.36M0.0%+114.5%0.178% Get the Latest News and Ratings for RANI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2023JPMorgan Chase & Co.6,525$27K0.0%+352.2%0.013% 8/10/2023King Luther Capital Management Corp56,129$0.23M0.0%N/A0.113% 8/4/2023Choreo LLC19,813$82K0.0%-20.2%0.040% 5/16/2023Susquehanna International Group LLP70,772$0.37M0.0%N/A0.143% 5/12/2023Renaissance Technologies LLC41,117$0.21M0.0%+7.1%0.083% 5/12/2023Bank of America Corp DE13,451$69K0.0%+250.9%0.027% 5/12/2023HRT Financial LP18,098$93K0.0%N/A0.037% 5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026% 5/11/2023Alphabet Inc.448,492$2.31M0.1%-12.1%0.908% 2/15/2023Jane Street Group LLC12,929$76K0.0%N/A0.026% 2/15/2023Millennium Management LLC73,144$0.43M0.0%-17.9%0.148% 2/13/2023Brown Advisory Inc.33,911$0.20M0.0%N/A0.069% 2/13/2023Renaissance Technologies LLC38,400$0.23M0.0%N/A0.078% 2/13/2023Geode Capital Management LLC97,185$0.57M0.0%+2.8%0.197% 2/8/2023 Prime Capital Investment Advisors LLC33,502$0.20M0.0%N/A0.068% 11/18/2022TPB Wealth Advisors48,129$0.46M0.2%-33.0%0.098% 11/16/2022Alphabet Inc.714,471$6.85M0.3%N/A1.453% 11/15/2022Jacobs Levy Equity Management Inc.18,712$0.18M0.0%N/A0.038% 11/15/2022Vanguard Group Inc.650,978$6.24M0.0%+95.4%1.324% 11/15/2022BlackRock Inc.202,907$1.94M0.0%-1.9%0.413% 11/3/2022Motco48,129$0.46M0.0%N/A0.098% 10/28/2022 Lafayette Investments Inc.19,893$0.19M0.1%N/A0.040% 10/17/2022 Canton Hathaway LLC16,200$0.16M0.1%+88.4%0.033% 10/14/2022 Iowa State Bank18,862$0.18M0.1%N/A0.038% 8/18/2022Goldman Sachs Group Inc.10,739$0.11M0.0%-60.0%0.022% 8/15/2022Millennium Management LLC111,781$1.16M0.0%+243.7%0.227% 8/8/2022Islay Capital Management LLC9,611$99K0.1%N/A0.020% 8/8/2022Crossvault Capital Management LLC14,285$0.15M0.1%N/A0.029% 7/29/2022Aspireon Wealth Advisors71,811$0.74M0.3%N/A0.146% 7/20/2022 Canton Hathaway LLC8,600$89K0.0%N/A0.017% 6/15/2022Lasry Marc62,828$0.85M0.4%N/A0.128% 6/7/2022Bank of America Corp DE3,155$42K0.0%-28.7%0.006% 5/17/2022Lasry Marc62,828$0.85M0.4%N/A0.128% 5/16/2022Goldman Sachs Group Inc.26,820$0.36M0.0%N/A0.055% Investors Alert: The Next Big Thing in Weight Loss (Ad)History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all...The profit window is closing - don't get left behind!5/16/2022State Street Corp26,142$0.35M0.0%+32.7%0.053% 5/16/2022UBS Group AG3,570$48K0.0%-31.2%0.007% 5/13/2022Vanguard Group Inc.290,107$3.92M0.0%+1.6%0.590% 5/13/2022United Services Automobile Association481,300$6.50M0.1%N/A0.979% 5/12/2022BlackRock Inc.157,374$2.13M0.0%+37.7%0.320% 5/11/2022JPMorgan Chase & Co.2,329$31K0.0%-44.4%0.005% 5/4/2022Advisor Group Holdings Inc.19,343$0.26M0.0%-8.2%0.039% 2/3/2022Advisor Group Holdings Inc.21,072$0.34M0.0%N/A0.043% 1/6/2022 Canton Hathaway LLC5,000$82K0.0%-50.0%0.010% 11/16/2021Squarepoint Ops LLC50,000$0.89M0.0%N/A0.102% 11/15/2021Caas Capital Management LP75,000$1.34M0.0%N/A0.153% 11/10/2021Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124% (Data available from 1/1/2016 forward) RANI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RANI shares? During the previous two years, 34 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were United Services Automobile Association ($6.50M), Vanguard Group Inc. ($6.24M), Alphabet Inc. ($2.31M), BlackRock Inc. ($1.94M), Lasry Marc ($0.85M), Aspireon Wealth Advisors ($0.74M), and Geode Capital Management LLC ($0.57M).Learn more on RANI's institutional investors. What percentage of Rani Therapeutics stock is owned by institutional investors? 30.19% of Rani Therapeutics stock is owned by institutional investors. Learn more on RANI's institutional investor holdings. Which institutional investors have been buying Rani Therapeutics stock? Of the 29 institutional investors that purchased Rani Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alphabet Inc. ($0.71M), United Services Automobile Association ($0.48M), Vanguard Group Inc. ($0.32M), Lasry Marc ($0.13M), Stifel Financial Corp ($0.11M), Renaissance Technologies LLC ($88.20K), and Millennium Management LLC ($79.26K). How much institutional buying is happening at Rani Therapeutics? Institutional investors have bought a total of 2,470,184 shares in the last 24 months. This purchase volume represents approximately $24.23M in transactions. Which Rani Therapeutics major shareholders have been selling company stock? Of the 12 institutional investors that sold Rani Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Stifel Financial Corp ($91.64K), Alphabet Inc. ($61.64K), Alpha Square Group S LLC ($28K), TPB Wealth Advisors ($23.68K), Goldman Sachs Group Inc. ($16.08K), Millennium Management LLC ($15.99K), and Choreo LLC ($5K). How much institutional selling is happening at Rani Therapeutics? Institutional investors have sold a total of 252,426 shares in the last 24 months. This volume of shares sold represents approximately $1.35M in transactions. Related Companies: IVA Major Shareholders GTHX Major Shareholders ALDX Major Shareholders ABEO Major Shareholders GLYC Major Shareholders IXHL Major Shareholders RLMD Major Shareholders SCPH Major Shareholders OPTN Major Shareholders ATOS Major Shareholders This page (NASDAQ:RANI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.